Empowering Angel Syndicate Investment

Halo Business Angel Network is an all-island umbrella group responsible for the development of business angel syndicates on the island of Ireland. HBAN is actively working to increase the number of angel investors who are interested in investing in early stage technology, MedTech, AgriTech & food companies and supporting the early stage entrepreneurial community.

Find Out More

 

Syndicates

Syndicates

If you wish to mitigate risk in angel investing through building a diversified portfolio of investments then the syndicate model is for you. HBAN can connect you to like minded investors with similar investment interests.

Investors

Investors

Are you looking to get access to ambitious companies with growth potential? Are you looking to invest in new high potential start ups from Ireland’s emerging knowledge sector? Then speak to HBAN today.

Entrepreneurs

Entrepreneurs

If you are an early stage company in the knowledge sector looking for funds, we’d like to hear from you. Working with HBAN will ensure you have the best chance of raising finance.

HBAN Food Investor Forum

Apr-17-2019
HBAN will hold the first Food Investor Forum of 2019 on 21st May in Dublin . The half-day event will bring together current HBAN Food Syndicate Investors, other HBAN Investors interested in the food sector and New Investors interested in getting involved in food investing. It will also bring together other key stakeholders in the food industry including Kerry Group, Finistere (a later stage US and Irish Food and Agtech focused VC), and leaders of successful scaled Food companies to share their market insights and experience. A selection of 4 food sector entrepreneurs from across the broad food supply chain (from production, packaging and distribution) will pitch to investors to raise investment.

Signum Surgical Receives €3.6 Million in Grant Funding to Support Launch of Therapy for Patients with a Common Colorectal Disease

Apr-8-2019
Signum Surgical, a company dedicated to developing minimally invasive technologies to treat colorectal diseases, today announced the company has secured €3.6 million ($4 million) through two grant funding awards. The grants include €2.3 million from the European Union Horizon 2020 SME Instrument, and €1.3 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF). Funds from these grants will support regulatory and clinical programs leading to the commercialization of the company’s BioHealxTM device, which is designed to treat anal fistula, a painful colorectal condition that affects one in 5,000 people worldwide.